2,200
Participants
Start Date
October 1, 2015
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
cyclophosphamide, vincristine, prednisone, dacarbazine
28-day chemotherapy cycle
cyclo, vcr, pred, dacarb,etop and doxo
21-day chemotherapy cycle
Our Lady's Children's Hospital, Crumlin, Dublin
CHUV - Centre Hospitalier Universitaire Vaudois = LS, Départment femme - meré - enfant, Service de pédiatrie, Unité d'hématologie-oncologie pédiatrique, Lausanne
St. Anna Kinderspital, Vienna
Starship Blood and Cancer Centre, Starship Children's Hospital, Auckland
Department of Pediatric Hematology/Oncology (5054) The Child and Youth Clinic, University Hospital of Copenhagen, Copenhagen
Paediatric haemato-oncology, University Hospitals of Leuven, Leuven
Royal Children's Hospital and Monash Medical Centre Royal Children's Hospital, Victoria Park
Princess Máxima Center for pediatric oncology, Utrecht
Dpt. of Pediatric Hematology and Oncology, Faculty Hospital Motol, Prague
Pediatric Radiotherapy and Youth Area Unit C.R.O. - Centro di Riferimento Oncologico IRCCS, Aviano
Justus Liebig University of Giessen, Giessen
Sección de Onco-Hematología Pediátrica Hospital Universitario Virgen Macarena y Virgen del Rocío, Seville
Tel Aviv University Schneider Children's Medical Center of Israel The Rina Zaizov Pediatric Hematology Oncology Division, Petah Tikva
Pediatric Hematology & Oncology Children´s University Hospital, Uppsala
Service d'Oncohématologie, Hopital d'Ènfants Armand Trousseau, Paris
Clinic of Pediatric Oncology University Children's Hospital, Bratislava
Department of Medical Oncology Oslo University Hospital, Oslo
Head of Department of Pediatric Oncology and Hematology, Polish-American Pediatric Institute, Jagiellonian University Medical Faculty, Krakow
University College London Hospitals, London
Deutsche Krebshilfe e.V., Bonn (Germany)
OTHER
Euronet Worldwide
OTHER
University of Giessen
OTHER